Yayın: Contrast medium enhanced susceptibility imaging signal mechanism; should we use contrast medium?
| dc.contributor.author | Aydın, Ömer | |
| dc.contributor.author | Büyükkaya, Ramazan | |
| dc.contributor.buuauthor | Hakyemez, Bahattin | |
| dc.contributor.department | Tıp Fakültesi | |
| dc.contributor.department | Radyoloji Ana Bilim Dalı | |
| dc.contributor.orcid | 0000-0002-3425-0740 | |
| dc.contributor.researcherid | AAI-2318-2021 | |
| dc.contributor.scopusid | 6602527239 | |
| dc.date.accessioned | 2023-01-30T11:39:48Z | |
| dc.date.available | 2023-01-30T11:39:48Z | |
| dc.date.issued | 2017-01-01 | |
| dc.description.abstract | Background Intracranial lesions exhibit clear contrast enhancement in T1-weighted imaging, but the mechanism whereby contrast-enhanced susceptibility-weighted imaging (CE-SWI) generates signals remains unclear. Contrast enhancement patterns cannot be reliably predicted. Purpose To explore the mechanism of CE-SWI contrast enhancement. Material and Methods Fifty-five patients were retrospectively enrolled. All of the imaging employed a clinical 3T magnetic resonance imaging (MRI) system fitted with a 32-channel head coil. Minimum-intensity projection reformatted images were evaluated. Intracranial lesions and brain parenchymal intensities were explored using SWI and CE-SWI. signal intensity rates were calculated by dividing the lesional intensity by the white matter intensity, after which the SWI and CE-SWI signal intensity rate were compared. Two observers independently performed intralesional susceptibility signal analysis. Results After contrast medium administration, malignant and extra-axial tumors exhibited obvious contrast enhancement on CE-SWI (P<0.001 and P=0.013, respectively). The signal intensity of white matter was significantly reduced. The signal intensity rates rose significantly in the benign, malignant, and extra-axial groups (P<0.001). Between-radiologist agreement in terms of intralesional susceptibility signal assessment was strong (kappa=0.8, P<0.001). Conclusion Contrast media can either reduce or increase SWI signal intensities. The dual contrast feature of CE-SWI can be useful when exploring intracranial disorders. | |
| dc.identifier.citation | Aydın, Ö. vd. (2017). ''Contrast medium enhanced susceptibility imaging signal mechanism; should we use contrast medium?''. Acta Radiologica, 58(1), 107-113. | |
| dc.identifier.doi | 10.1177/0284185116637246 | |
| dc.identifier.endpage | 113 | |
| dc.identifier.issn | 0284-1851 | |
| dc.identifier.issue | 1 | |
| dc.identifier.pubmed | 26966145 | |
| dc.identifier.scopus | 2-s2.0-85006483742 | |
| dc.identifier.startpage | 107 | |
| dc.identifier.uri | https://doi.org/10.1177/0284185116637246 | |
| dc.identifier.uri | 1600-0455 | |
| dc.identifier.uri | https://journals.sagepub.com/doi/10.1177/0284185116637246 | |
| dc.identifier.uri | http://hdl.handle.net/11452/30713 | |
| dc.identifier.volume | 58 | |
| dc.identifier.wos | 000390557900015 | |
| dc.indexed.wos | SCIE | |
| dc.language.iso | en | |
| dc.publisher | Sage Puplications | |
| dc.relation.collaboration | Yurt içi | |
| dc.relation.collaboration | Sanayi | |
| dc.relation.journal | Acta Radiologica | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Radiology, nuclear medicine & medical imaging | |
| dc.subject | Contrast medium | |
| dc.subject | Susceptibility weighted imaging | |
| dc.subject | Blood brain barrier | |
| dc.subject | Angiogenesis | |
| dc.subject | Tumor | |
| dc.subject | High-resolution | |
| dc.subject | Radiation necrosis | |
| dc.subject | Grade gliomas | |
| dc.subject | Brain | |
| dc.subject | Differentiation | |
| dc.subject | Patterns | |
| dc.subject | Magnetic resonance imaging | |
| dc.subject | Tissue | |
| dc.subject | Tumors | |
| dc.subject | Angiogenesis | |
| dc.subject | Blood-brain barrier | |
| dc.subject | Contrast enhancement | |
| dc.subject | Contrast medium | |
| dc.subject | Contrast-enhanced | |
| dc.subject | Signal intensities | |
| dc.subject | Susceptibility weighted Imaging | |
| dc.subject | White matter | |
| dc.subject | Contrast media | |
| dc.subject.emtree | Gadoterate meglumine | |
| dc.subject.emtree | Contrast medium | |
| dc.subject.emtree | Gadoterate meglumine | |
| dc.subject.emtree | Meglumine | |
| dc.subject.emtree | Organometallic compound | |
| dc.subject.emtree | Adolescent | |
| dc.subject.emtree | Aged | |
| dc.subject.emtree | Article | |
| dc.subject.emtree | Benign neoplasm | |
| dc.subject.emtree | Brain cancer | |
| dc.subject.emtree | Brain damage | |
| dc.subject.emtree | Brain tissue | |
| dc.subject.emtree | Child | |
| dc.subject.emtree | Contrast enhancement | |
| dc.subject.emtree | Controlled study | |
| dc.subject.emtree | Female | |
| dc.subject.emtree | Human | |
| dc.subject.emtree | Image analysis | |
| dc.subject.emtree | Image display | |
| dc.subject.emtree | Image processing | |
| dc.subject.emtree | Intermethod comparison | |
| dc.subject.emtree | Interrater reliability | |
| dc.subject.emtree | Intracranial tumor | |
| dc.subject.emtree | Major clinical study | |
| dc.subject.emtree | Male | |
| dc.subject.emtree | Nuclear magnetic resonance scanner | |
| dc.subject.emtree | Parenchyma | |
| dc.subject.emtree | Priority journal | |
| dc.subject.emtree | Retrospective study | |
| dc.subject.emtree | Signal detection | |
| dc.subject.emtree | Susceptibility weighted imaging | |
| dc.subject.emtree | White matter | |
| dc.subject.emtree | Adult | |
| dc.subject.emtree | Brain tumor | |
| dc.subject.emtree | Complication | |
| dc.subject.emtree | Computer assisted diagnosis | |
| dc.subject.emtree | Diagnostic imaging | |
| dc.subject.emtree | Image enhancement | |
| dc.subject.emtree | Magnetic resonance angiography | |
| dc.subject.emtree | Middle aged | |
| dc.subject.emtree | Neovascularization (pathology) | |
| dc.subject.emtree | Preschool child | |
| dc.subject.emtree | Procedures | |
| dc.subject.emtree | Reproducibility | |
| dc.subject.emtree | Sensitivity and specificity | |
| dc.subject.emtree | Young adult | |
| dc.subject.mesh | Adolescent | |
| dc.subject.mesh | Adult | |
| dc.subject.mesh | Aged | |
| dc.subject.mesh | Brain neoplasms | |
| dc.subject.mesh | Child | |
| dc.subject.mesh | Child, preschool | |
| dc.subject.mesh | Contrast media | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Image enhancement | |
| dc.subject.mesh | Image interpretation, computer-assisted | |
| dc.subject.mesh | Magnetic resonance angiography | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Meglumine | |
| dc.subject.mesh | Middle aged | |
| dc.subject.mesh | Neovascularization, pathologic | |
| dc.subject.mesh | Organometallic compounds | |
| dc.subject.mesh | Reproducibility of results | |
| dc.subject.mesh | Sensitivity and specificity | |
| dc.subject.mesh | Young adult | |
| dc.subject.scopus | Substantia Nigra; Susceptibility; Pulvinar | |
| dc.subject.wos | Radiology, nuclear medicine & medical imaging | |
| dc.title | Contrast medium enhanced susceptibility imaging signal mechanism; should we use contrast medium? | |
| dc.type | Article | |
| dc.wos.quartile | Q3 | |
| dspace.entity.type | Publication | |
| local.contributor.department | Tıp Fakültesi/Radyoloji Ana Bilim Dalı | |
| local.indexed.at | Scopus | |
| local.indexed.at | WOS |
Dosyalar
Lisanslı seri
1 - 1 / 1
